2008 TABLE OF CONTENTS

Section 1: Science & International

• Fibrin Microbeads (FMB): Applications in Cell-Based Tissue Regeneration and Stem Cell Research
  Professor Raphael Gorodetsky, Ph.D.

• The U.S. National Stem Cell Bank: Cell Distribution and Technical Support Services for Human ES Cell Researchers
  Derek J. Hei, Ph.D.

• Aging: A Foreseeable Target of Stem Cells and Regenerative Medicine
  Aubrey D.N.J. de Grey, Ph.D.

• Stem Cells and Aging: A Conversation with Bill Haseltine
  Eve Herold

• The Challenges for Banking Human Stem Cell Lines
  Glyn Stacey, Ph.D.

• Expanding the Territory of Stem Cell Medicine
  Mark Noble, Chris Proschel and Margot Mayer-Proschel

• Stem Cell Research: The Next Frontier in India
  Abner M. Mhashilkar, Ph.D.

• Spotlight on Scotland's Stem Cell Industry
  Marilyn Robertson, Ph.D.

• Stem Cell Research in Australia: Collaboration, Legislation, Scientists and Public Accountability
  Rebecca Skinner and Aimee Sanderson

• The Canadian Way: Investing in Regenerative Medicine
  Joe Sornberger

Section 2: Stem Cell Research in Wisconsin

• Wisconsin's Stem Cell Climate: Public Sector Support from the Laboratory to the Global Marketplace
  The Office of Governor Jim Doyle

• The WiCell Institute
  Erik J. Fosberg, Ph.D.

• University of Wisconsin Stem Cell and Regenerative Medicine Center: An Overview of Stem Cell Research and Innovation
  Timothy Kamp, M.D., Ph.D. and Clive N. Svendsen, Ph.D.

• Driving Embryonic Stem Cells Towards Beta Cells: Lessons from Embryos
  Jon S. Odorico M.D., F.A.C.S.

• Repair of Myelin Disease through Transplantation of Stem Cells or their Progenitors
  Ian Duncan, BVMS, Ph.D.

• Metabolomics of Human Embryonic Stem Cells
  Jessica A. Quam, M.S. and Gabriela G. Cezar, D.V.M., Ph.D.

• Highlights of Key Research: Clive Svendsen's Lab
  Allison Ebert, Ph.D.

• New Tools to Study Human Stem Cells
  Soshana Svendsen, Ph.D., Nadine Nassif, M.S., Ilgar Abbaszade, Ph.D., Doug Storts, Ph.D., Georgyi V. Los, Ph.D., and Clive N. Svendsen, Ph.D.

Section 3: Law & Policy

• After the Fall: Federal Stem Cell Policy in the Next Generation
  Michael J. Werner, Esq.

• On Stem Cell Travel and the Need for Clinical Trials
  Sorapop Kiatpongsan, M.D. and Douglas Sipp

• Legal Issues in Patenting Human Pluripotent Cells
  Brian C. Cholewa, J.D., Ph.D.

• Outline of Legal Aspects Concerning Research on Stem Cells in Italy and Europe
  Fabio Marazzi, Esq.

Section 4: Ethics & Advocacy

• An Ethical Evaluation of Altered Nuclear Transfer-Cdx2
  Robert Streiffer, Ph.D.

• "We" and "They" Imagine the Early Embryo: Some Psychological Considerations in the Stem Cell "Wars"
  Stephen E. Levick, M.D.

• Close, But Not Quite There
  Jeff Sheehy

• How to Pass a Stem Cell Law
  Don C. Reed

Section 5: Business

• Breaking the Stem Cell Technology Barrier: Designing Renewable, Physiologically Functional Cells for Modern Drug Discovery
  John E. Hambor, Ph.D.

• Commercialization of the DECELL|RECELL Technology Platform
  Sarah A. Haecker, Ph.D., Barbara A. Nelsen, Ph.D. and Doris A. Taylor, Ph.D.

• Stem Cells as A Business: A Pragmatic Approach
  Nick Seay

• Filling the Commercialization Gap in Stem Cell Technologies: Case Studies of Successful Partnerships with Academia and Industry Cliver Glover, Ph.D. and Tiffany Chiu, BSc

• Role for Human Embryonic Stem Cells in Teratogenicity Screening
  Gabriela G. Cezar, D.V.M., Ph.D., Elizabeth L.R. Donley, J.D., M.B.A., M.S.

• Successful Business Models for Cell-Based Therapies
  Devyn M. Smith, Ph.D.

• Business of Stem Cells: Business of Hope
  Sorapop Kiatpongsan, M.D. and Debora L. Spar, Ph.D.